SITAVIB 50SITAGLIPTIN PHOSPHATE 50mg. IP

Sitavib 50 tablets with Sitagliptin Phosphate 50 mg help improve blood sugar control in adults with type 2 diabetes, along with diet and exercise. Main uses: used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus; helps lower raised blood glucose as part of a diabetes management plan set by a doctor; suitable as add-on therapy when diet, exercise and other diabetes medicines do not give enough control, as directed by a doctor.

Common side effects of Sitavib 50 Tablet include upper respiratory tract infection; nasopharyngitis (inflammation of the nose and throat); headache; low blood sugar, mainly when taken with insulin or a sulfonylurea; constipation; back pain. Get medical help at once if you notice pancreatitis (inflammation of the pancreas, with severe stomach pain); serious allergic and skin reactions, including anaphylaxis, angioedema, and severe skin conditions such as Stevens-Johnson syndrome and other exfoliative skin reactions; acute renal failure, sometimes needing dialysis.

Each Sitavib 50 tablet contains Sitagliptin Phosphate 50 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Sitavib 50 Tablet only as your doctor advises.

The MRP of Sitavib 50 Tablet is ₹102 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹77.71 and the PTS is ₹69.94.

Each Sitavib 50 tablet contains Sitagliptin Phosphate 50 mg. It comes in a pack of 10x10 (Blister).

The active ingredient in these tablets acts by slowing the inactivation of the incretin hormones the intestine releases in response to a meal. By keeping these hormones working for longer, it supports the release of insulin from the pancreas when blood sugar is raised.

Must not be used in patients with type 1 diabetes. Must not be used by anyone who has had a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema. Check with a doctor first if there is a history of pancreatitis, as this medicine has not been studied in such patients. Check with a doctor first if there is kidney disease, heart failure or risk factors for heart failure. Check with a doctor first if insulin or a sulfonylurea is being taken, as the insulin or sulfonylurea dose may need adjustment.

Sitavib 50 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.